Role of immunotherapy in metastatic renal cell cancer: past, present and future | Zendy

Amos Lal | Zendy; Kamal Kant Sahu | Zendy; Vishal Jindal | Zendy; Ajay Kumar Mishra | Zendy; Ahmad Daniyal Siddiqui | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Role of immunotherapy in metastatic renal cell cancer: past, present and future

Author(s) -

Amos Lal,

Kamal Kant Sahu,

Vishal Jindal,

Ajay Kumar Mishra,

Ahmad Daniyal Siddiqui

Publication year - 2019

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2019.09.95

Subject(s) - immunotherapy , medicine , renal cell carcinoma , cancer , oncology , lung cancer , cancer immunotherapy , metastasis , kidney cancer , cancer research

It was only in the late 90s when the link between the immunology and oncology was known to scientists. Tumor shrinkage of sarcoma following injection of killed bacteria noted by Coley was one of the earlier observations which led to considering immunotherapy in cancer treatment (1). Although the initial studies on interferon gamma-1b failed to improve outcomes in metastatic renal cell carcinoma (mRCC) (2), cases of spontaneous regression of metastatic lung lesions perpetuated investigations to study the potential role of immunotherapy in mRCC (3).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research